Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis
Before the advent of anti-tuberculosis drugs in the 1940s, tuberculous meningitis (TBM) was a much-feared and almost universally fatal form of tuberculosis. Thus, when the first anti-tuberculosis drugs, streptomycin and para-aminosalycilic acid, became available, they were given first to those with...
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Journal article |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Elsevier
2023
|